Champions Oncology, Inc. (CSBR)
4.97
+0.01
(+0.20%)
USD |
NASDAQ |
Aug 24, 16:00
4.99
+0.02
(+0.40%)
After-Hours: 20:00
Champions Oncology Enterprise Value : 68.87M for Aug. 24, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 68.87M |
| August 21, 2026 | 68.73M |
| August 20, 2026 | 71.79M |
| August 19, 2026 | 68.46M |
| August 18, 2026 | 70.54M |
| August 17, 2026 | 69.71M |
| August 14, 2026 | 70.19M |
| August 13, 2026 | 70.40M |
| August 12, 2026 | 68.59M |
| August 11, 2026 | 69.15M |
| August 10, 2026 | 71.23M |
| August 07, 2026 | 71.93M |
| August 06, 2026 | 71.93M |
| August 05, 2026 | 73.46M |
| August 04, 2026 | 75.54M |
| August 03, 2026 | 79.84M |
| July 31, 2026 | 74.29M |
| July 30, 2026 | 72.90M |
| July 29, 2026 | 75.68M |
| July 28, 2026 | 76.65M |
| July 27, 2026 | 84.01M |
| July 24, 2026 | 84.98M |
| July 23, 2026 | 83.18M |
| July 22, 2026 | 84.98M |
| July 21, 2026 | 84.56M |
| Date | Value |
|---|---|
| July 20, 2026 | 84.56M |
| July 17, 2026 | 84.98M |
| July 16, 2026 | 80.95M |
| July 15, 2026 | 80.12M |
| July 14, 2026 | 78.45M |
| July 13, 2026 | 80.54M |
| July 10, 2026 | 80.68M |
| July 09, 2026 | 80.54M |
| July 08, 2026 | 84.09M |
| July 07, 2026 | 81.51M |
| July 06, 2026 | 81.09M |
| July 02, 2026 | 79.84M |
| July 01, 2026 | 83.80M |
| June 30, 2026 | 85.40M |
| June 29, 2026 | 89.15M |
| June 26, 2026 | 91.92M |
| June 25, 2026 | 84.29M |
| June 24, 2026 | 85.12M |
| June 23, 2026 | 86.37M |
| June 22, 2026 | 86.65M |
| June 18, 2026 | 87.62M |
| June 17, 2026 | 94.56M |
| June 16, 2026 | 95.40M |
| June 15, 2026 | 87.90M |
| June 12, 2026 | 90.12M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Medpace Holdings, Inc. | 16.90B |
| Avantor, Inc. | 13.04B |
| Personalis, Inc. | 1.640B |
| Adaptive Biotechnologies Corp. | 4.138B |
| 10X Genomics, Inc. | 7.839B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.667M |
| Revenue (Quarterly) | 13.84M |
| Total Expenses (Quarterly) | 14.50M |
| EPS Diluted (Quarterly) | -0.048 |
| Gross Profit Margin (Quarterly) | 48.77% |
| Profit Margin (Quarterly) | -4.82% |
| Earnings Yield | -1.63% |
| Normalized Earnings Yield | -1.634 |